ConceptioArchiveHAL (France)
HAL (France)open access

Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study

Do-Youn Oh et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
0, 1, 2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 326100
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.